Topics

J&J to invest $500m in HIV and TB therapies research

19:00 EDT 6 Oct 2019 | Pharmaceutical Technology

Johnson & Johnson (J&J) has announced plans to invest over $500m towards research and development of HIV and tuberculosis (TB)...
Read More...

The post J&J to invest $500m in HIV and TB therapies research appeared first on Pharmaceutical Technology.

Original Article: J&J to invest $500m in HIV and TB therapies research

NEXT ARTICLE

More From BioPortfolio on "J&J to invest $500m in HIV and TB therapies research"

Quick Search

Relevant Topic

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...